For the other organs, we observed a reduction in the [ 68 Ga]Ga-DFO-ND-Oct radioactivity concentration in blood, plasma, tumor, and spleen, and an increase in liver and lung compared to [ 68 Ga]Ga-DFO-ND, although these differences did not reach statistical significance. 3.
← all excerpts
Functionalization of <sup>68</sup>Ga-Radiolabeled Nanodiamonds with Octreotide Does Not Improve Tumor-Targeting Capabilities.
1
—
—